Business
Cannabics' Dr. Moran Grinberg to Speak at the Annual CannaTech Conference
Cannabics' Dr. Moran Grinberg to Speak at the Annual CannaTech Conference.
About this update from Cnbx Pharmaceuticals Inc.
[{"type":"text","content":"\n\n\n\nCannabics' Dr. Moran Grinberg to Speak at the Annual CannaTech Conference\n\n\n\n\n\nCannabics' Dr. Moran Grinberg to Speak at the Annual CannaTech Conference\nPR Newswire\nTEL AVIV, Israel, February 28, 2018\n\n\n\nTEL AVIV, Israel, February 28, 2018 /PRNewswire/ --\n\nCannabics Pharmaceuticals, Inc. (OTCQB: CNBX) announced today that Dr. Moran Grinberg, VP of R&D, will speak at the Annual CannaTech Conference to be held in Tel-Aviv, Israel, March 19th-20th. CannaTech is a yearly conference of acknowledged leaders in science, research, medicine and government policy relating to medical cannabis.\n\n     (Logo: http://mma.prnewswire.com/media/485543/Cannabics_Logo.jpg )\n\n\nDr. Grinberg is appearing as a Key Note speaker for the Session \"Bringing Personalized Cannabinoid-based Medicine to the World\".\n\nIn her presentation, Dr. Grinberg will discuss the development of recent cancer diagnostics tools in conjunction with cannabinoid medicine. By utilizing state of the art High Throughput Screening technological systems and machine learning platforms, Cannabics aims to deliver precise data regarding the efficacy of various cannabinoid compounds on specific cancer types.\n\nAbout Cannabics Pharmaceuticals Inc. \n\nCannabics Pharmaceuticals Inc. (CNBX), a U.S based public company, is dedicated to the development of Personalized Anti-Cancer and Palliative treatments. The Company's R&D is based in Israel, where it is licensed by the Ministry of Health for its work in both scientific and clinical research. The Company's focus is on harnessing the therapeutic properties of natural Cannabinoid formulations and diagnostics. Cannabics engages in developing individually tailored natural therapies for cancer patients, utilizing advanced screening systems and personalized bioinformatics tools.\n\nDisclaimer: \n\nCertain statements contained in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to statements identified by words such as \"believes,\" \"expects,\" \"anticipates,\" \"estimates,\" \"intends,\" \"plans,\" \"targets,\" \"projects\" and similar expressions. The statements in this release are based upon the current beliefs and expectations of our com...